81 related articles for article (PubMed ID: 23143550)
1. Resting heart rate is a predictor of mortality in COPD.
Jensen MT; Marott JL; Lange P; Vestbo J; Schnohr P; Nielsen OW; Jensen JS; Jensen GB
Eur Respir J; 2013 Aug; 42(2):341-9. PubMed ID: 23143550
[TBL] [Abstract][Full Text] [Related]
2. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study.
Shavelle RM; Paculdo DR; Kush SJ; Mannino DM; Strauss DJ
Int J Chron Obstruct Pulmon Dis; 2009; 4():137-48. PubMed ID: 19436692
[TBL] [Abstract][Full Text] [Related]
3. E pluribus plurima: multidimensional indices and clinical phenotypes in COPD.
Rossi A; Zanardi E
Respir Res; 2011 Nov; 12(1):152. PubMed ID: 22082092
[No Abstract] [Full Text] [Related]
4. Heart rate variations in chronic obstructive pulmonary disease.
Roca M; Mitu F; Roca IC; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):616-22. PubMed ID: 24502025
[TBL] [Abstract][Full Text] [Related]
5. Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia.
Warnier MJ; Rutten FH; de Boer A; Hoes AW; De Bruin ML
PLoS One; 2014; 9(8):e105152. PubMed ID: 25157876
[TBL] [Abstract][Full Text] [Related]
6. The contribution of diet and lifestyle to socioeconomic inequalities in cardiovascular morbidity and mortality.
Méjean C; Droomers M; van der Schouw YT; Sluijs I; Czernichow S; Grobbee DE; Bueno-de-Mesquita HB; Beulens JW
Int J Cardiol; 2013 Oct; 168(6):5190-5. PubMed ID: 23998549
[TBL] [Abstract][Full Text] [Related]
7. Effects of smoking on heart rate at rest and during exercise, and on heart rate recovery, in young adults.
Papathanasiou G; Georgakopoulos D; Papageorgiou E; Zerva E; Michalis L; Kalfakakou V; Evangelou A
Hellenic J Cardiol; 2013; 54(3):168-77. PubMed ID: 23685653
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular disease in COPD: mechanisms.
Maclay JD; MacNee W
Chest; 2013 Mar; 143(3):798-807. PubMed ID: 23460157
[TBL] [Abstract][Full Text] [Related]
9. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
; Regitz-Zagrosek V; Oertelt-Prigione S; Prescott E; Franconi F; Gerdts E; Foryst-Ludwig A; Maas AH; Kautzky-Willer A; Knappe-Wegner D; Kintscher U; Ladwig KH; Schenck-Gustafsson K; Stangl V
Eur Heart J; 2016 Jan; 37(1):24-34. PubMed ID: 26530104
[No Abstract] [Full Text] [Related]
10. Myocardial remodeling in hypertension.
Nadruz W
J Hum Hypertens; 2015 Jan; 29(1):1-6. PubMed ID: 24804791
[TBL] [Abstract][Full Text] [Related]
11. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
12. Decreased heart rate variability in patients with chronic obstructive pulmonary disease.
Volterrani M; Scalvini S; Mazzuero G; Lanfranchi P; Colombo R; Clark AL; Levi G
Chest; 1994 Nov; 106(5):1432-7. PubMed ID: 7956396
[TBL] [Abstract][Full Text] [Related]
13. Non-drug treatment of hypertension.
Kaplan NM
Ann Intern Med; 1985 Mar; 102(3):359-73. PubMed ID: 3882040
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin 2 receptor blockers on chronic obstructive lung disease mortality: A retrospective cohort study.
Paulin P; Maritano Furcada J; Ungaro CM; Bendelman G; Waisman GD; Castro HM; Giunta DH; Ferreyro BL
Pulm Pharmacol Ther; 2017 Jun; 44():78-82. PubMed ID: 28315489
[TBL] [Abstract][Full Text] [Related]
15. Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective.
Anzueto A
COPD; 2015 Aug; 12(4):462-7. PubMed ID: 25474273
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Chen W; Thomas J; Sadatsafavi M; FitzGerald JM
Lancet Respir Med; 2015 Aug; 3(8):631-9. PubMed ID: 26208998
[TBL] [Abstract][Full Text] [Related]
17. COPD and Cardiovascular Disease.
André S; Conde B; Fragoso E; Boléo-Tomé JP; Areias V; Cardoso J;
Pulmonology; 2019; 25(3):168-176. PubMed ID: 30527374
[TBL] [Abstract][Full Text] [Related]
18. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease.
Böhm M; Reil JC; Deedwania P; Kim JB; Borer JS
Am J Med; 2015 Mar; 128(3):219-28. PubMed ID: 25447617
[TBL] [Abstract][Full Text] [Related]
19. Association between admission heart rate and in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: a retrospective cohort study.
Zhou R; Pan D
BMC Pulm Med; 2024 Mar; 24(1):111. PubMed ID: 38443791
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
